A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers

Summary

This 2-arm, open-label, non-randomized study will investigate the absolute bioavailability, pharmacokinetics, mass balance, and routes of elimination of GDC-0032 as well as its safety in healthy volunteers. Patients will receive either a single oral dose of GDC-0032 followed by a 14C-labeled IV dose of GDC-0032 or a single oral dose of 14C-labelled GDC-0032.

Timeline

Start

2013-11

Primary completion

2013-12

Completion

2013-12

Drugs

Indications

No indication recorded.